Mon, May 19, 12:42 PM (35 days ago)
**Kaya Holdings, Inc. (KAYS, OTCQB:KAYS)** **Financial Performance (Fiscal Year 2024):** - **Revenue:** $7,134,000 - **Net Income:** $(2,222,552,000) - **Operating Expenses:** $2,021,662,000 - **Earnings Per Share (EPS):** $(0.07) **Strategic Overview:** - **Business Focus:** Transition from cannabis to psychedelic treatments. - **Key Subsidiaries:** MJAI (discontinued), KBI, FDT. - **New Venture:** The Sacred Mushroom™, a psilocybin treatment center in Portland, Oregon. **Future Outlook:** - **Market Position:** Shifting from cannabis to psychedelic medicine. - **Growth Strategy:** Expanding psychedelic treatment centers and international operations. - **Risk Factors:** Dependence on capital raising, market volatility, regulatory changes. **Financial Condition:** - **Assets:** $216,369,000 - **Liabilities:** $17,344,502,000 - **Stockholders' Deficit:** $(17,128,132,000) - **Cash:** $39,668,000 **Market Position Changes:** - **Cannabis Operations:** Discontinued MJAI's retail cannabis business. - **Psychedelic Medicine:** Focus on developing and launching psychedelic treatment centers. **Risk Factors:** - **Liquidity:** Significant working capital deficiency. - **Operational:** Dependence on third-party financing and capital issuance. - **Market:** Volatility in sales and earnings due to regulatory and economic factors. **Amendment Highlights:** - **Changes:** No major changes in financial statements, focus on strategic shift. - **Impact:** Emphasis on new business ventures and future growth prospects.